{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:10:09Z","timestamp":1772539809956,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5759,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.exphem.2006.05.004","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T12:16:58Z","timestamp":1156940218000},"page":"1218-1228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy"],"prefix":"10.1016","volume":"34","author":[{"given":"Virna","family":"Marin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Dander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ettore","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martino","family":"Introna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2006.05.004_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.174.1.139","article-title":"Use of a SCID mouse\/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity","volume":"174","author":"Schmidt-Wolf","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.05.004_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1015415928521","article-title":"Studies of ex-vivo activated and expanded CD8+ NKT cells in humans and mice","volume":"22","author":"Verneris","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/bbmt.2001.v7.pm11349808","article-title":"Expansion of cytotoxic CD3+CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous haematopoietic cell transplantation","volume":"7","author":"Alvarnas","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.05.004_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.4049\/jimmunol.153.4.1687","article-title":"A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity","volume":"153","author":"Lu","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib5","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1182\/blood.V92.9.3318","article-title":"Expansion of Philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice","volume":"92","author":"Hoyle","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00262-004-0554-4","article-title":"Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma","volume":"53","author":"Schmidt","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.exphem.2006.05.004_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2002.03247.x","article-title":"Generation of cytokine-induced killer cells from leukemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts","volume":"116","author":"Linn","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib8","first-page":"1108","article-title":"Expansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy","volume":"85","author":"Lefterova","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2006.05.004_bib9","first-page":"1673","article-title":"Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells","volume":"21","author":"Schmidt-Wolf","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1083-8791(01)70014-6","article-title":"Engineering hematopoietic grafts: purified allogeneic haematopoietic stem cells plus expanded CD8+ NKT cells in the treatment of lymphoma","volume":"7","author":"Verneris","year":"2001","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.exphem.2006.05.004_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0167-5699(00)01735-7","article-title":"NKT cells: facts, functions and fallacies","volume":"21","author":"Godfrey","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.exphem.2006.05.004_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.15.1.535","article-title":"Mouse CD1-specific NK1 T cells: development, specificity, and function","volume":"15","author":"Bendelac","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2567.2000.00952.x","article-title":"Human invariant V\u03b124+ natural killer T cells activated by a \u03b1-galactosylceramide (KRN7000) have cytotoxic anti-tumor activity through mechanisms distinct from T cells and natural killer cells","volume":"99","author":"Nicol","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2006.05.004_bib14","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.4049\/jimmunol.159.12.5862","article-title":"TCR V\u03b124 and V\u03b211 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation","volume":"159","author":"Prussin","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.179.4.1285","article-title":"CD4 pos, NK1.1 pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3","volume":"179","author":"Yoshimoto","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.05.004_bib16","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.0.CO;2-G","article-title":"NKT cells are phenotypically and functionally diverse","volume":"29","author":"Hammond","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.188.5.867","article-title":"CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V\u03b124J\u03b1Q T cell receptor \u03b1 chains","volume":"188","author":"Exley","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.05.004_bib18","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.4049\/jimmunol.162.11.6410","article-title":"Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells","volume":"162","author":"Eberl","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib19","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/1521-4141(200109)31:9<2818::AID-IMMU2818>3.0.CO;2-1","article-title":"Kuchroo VK Characterization of the phenotype and function of CD8(+) alpha\/beta (+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple targets","volume":"31","author":"Stremmel","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib20","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood.V97.10.2923","article-title":"Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production","volume":"97","author":"Baker","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2004-04-1537","article-title":"CD1d-unrestricted human NKT cells release chemokines upon Fas engagement","volume":"105","author":"Giroux","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2004.03.003","article-title":"The immunoregulatory role of CD1d-restricted natural killer T cells in disease","volume":"112","author":"van der Vliet","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1471-4906(03)00162-5","article-title":"Liver NKT cells: an account of heterogeneity","volume":"24","author":"Emoto","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib24","first-page":"3494","article-title":"Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole body irradiation","volume":"38","author":"Watanabe","year":"1978","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2006.05.004_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib26","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V99.11.4100","article-title":"The nonobese diabetic\/sever combined immunodeficient (NOD\/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biological characteristics at diagnosis and relapse","volume":"99","author":"Lock","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"14","author":"Imai","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.05.004_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib29","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood.V98.12.3359","article-title":"Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy","volume":"98","author":"Montagna","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib30","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/sj.emboj.7600361","article-title":"Defective dendritic cell migration and activation of adoptive immunity in PI3Kgamma-deficient mice","volume":"23","author":"Del Prete","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2006.05.004_bib31","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","article-title":"Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia","volume":"79","author":"Manabe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib32","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.4049\/jimmunol.151.10.5135","article-title":"Migration of natural killer cells across endothelial cell monolayers","volume":"151","author":"Bianchi","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib33","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4049\/jimmunol.166.4.2317","article-title":"Lysophosphatidic acid-receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane","volume":"166","author":"Zheng","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2141.1998.01020.x","article-title":"Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cells","volume":"103","author":"Introna","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-065X.2002.18611.x","article-title":"Alpha4 integrins and the immune response","volume":"186","author":"Rose","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.exphem.2006.05.004_bib36","doi-asserted-by":"crossref","first-page":"14423","DOI":"10.1073\/pnas.95.24.14423","article-title":"Endothelial selectins and vascular adhesion-molecule-1 promote hematopoietic progenitor homing to bone marrow","volume":"95","author":"Frenette","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.exphem.2006.05.004_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00062752-199502010-00010","article-title":"The L-selectin adhesion system","volume":"2","author":"Stamenkovic","year":"1995","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib38","first-page":"408","article-title":"A chemokine, SDF-1\/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis","volume":"72","author":"Nagasawa","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib39","doi-asserted-by":"crossref","unstructured":"Lapidot T. Mechanism of human stem cell migration and repopulation of NOD\/SCID and B2mnull NOD\/SCID mice. The role of SDF-1\/CXCR4 interactions. Ann N Y Acad Sci. 2001;938:83\u201395.","DOI":"10.1111\/j.1749-6632.2001.tb03577.x"},{"key":"10.1016\/j.exphem.2006.05.004_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","article-title":"The CC chemokine CCL20 and its receptor CCR6","volume":"14","author":"Schutyser","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.exphem.2006.05.004_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2001-12-0196","article-title":"Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V\u03b124+\u03b211+ NKT cell subsets with distinct cytokine-producing capacity","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib42","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.166.11.6477","article-title":"Unique subpopulation of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire","volume":"166","author":"Campbell","year":"2001","journal-title":"J. Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib43","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/jvi.67.4.2209-2220.1993","article-title":"Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors","volume":"67","author":"Birkenbach","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2006.05.004_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.mn.7800197","article-title":"Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking","volume":"10","author":"Muller","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.exphem.2006.05.004_bib45","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","article-title":"The chemokine SDF-1 activates the integrins LFA-1, VLA-4 and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice","volume":"95","author":"Peled","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.05.004_bib46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI10329","article-title":"Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function","volume":"106","author":"Ponomaryov","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.05.004_bib47","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1074\/jbc.272.21.13803","article-title":"Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7","volume":"272","author":"Yoshida","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2006.05.004_bib48","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.5.2418","article-title":"CK beta-11\/macrophage inflammatory protein-3 beta\/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells","volume":"160","author":"Kim","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.95.1.258","article-title":"A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of na\u00efve T lymphocytes","volume":"95","author":"Gunn","year":"1998","journal-title":"Proc Natl Acad U S A"},{"key":"10.1016\/j.exphem.2006.05.004_bib50","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.159.4.1589","article-title":"Identification and characterization of a novel beta chemokine containing six conserved cysteines","volume":"159","author":"Hedrick","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2006.05.004_bib52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/eji.200324718","article-title":"Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells","volume":"34","author":"Franitza","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib53","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.147.8.2565","article-title":"Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion","volume":"147","author":"Spertini","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.177.3.833","article-title":"Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin","volume":"177","author":"Kansas","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.05.004_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0167-5699(99)01469-3","article-title":"The chemokine system: redundancy for robust outputs","volume":"20","author":"Mantovani","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.exphem.2006.05.004_bib56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1471-4906(02)02323-2","article-title":"Distinct subsets of human V\u03b124-invariant NKT cells: cytokine responses and chemokine receptor expression","volume":"11","author":"Kim","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri841","article-title":"T-cell-receptor gene therapy","volume":"2","author":"Schumacher","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2006.05.004_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc971","article-title":"Targeting tumours with genetically enhanced T lymphocytes","volume":"3","author":"Sadelain","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2006.05.004_bib59","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0301-472X(00)00532-4","article-title":"Differential MMP and TIMP production by human marrow and peripheral blood CD34+ cells in response to chemokines","volume":"28","author":"Janowska-Wieczorek","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib60","first-page":"3399","article-title":"Expression of Fas ligand in newly diagnosed childhood acute lymphoblastic leukemia","volume":"19","author":"Volm","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.exphem.2006.05.004_bib61","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0301-472X(99)00091-0","article-title":"Fas\u00a0ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis","volume":"27","author":"Lickliter","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2006.05.004_bib62","unstructured":"Introna M, Borleri GM, Conti E. Ex vivo generation and characterization of cytokine induced killer cells in GMP conditions. Paper presented at the Annual International Society of Cell Therapy Meeting, Vancouver, Canada, May 4, 2005."},{"key":"10.1016\/j.exphem.2006.05.004_bib63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.bjc.6690800","article-title":"Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma","volume":"81","author":"Schmidt-Wolf","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2006.05.004_bib64","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3748\/wjg.v10.i8.1146","article-title":"Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma","volume":"10","author":"Shi","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.exphem.2006.05.004_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbmt.2004.11.019","article-title":"A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma","volume":"11","author":"Leemhuis","year":"2005","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06003158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06003158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:22:37Z","timestamp":1759566157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X06003158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0301472X06003158"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2006.05.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2006.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}